Leptin and the Control of Body Weight: A Review of Its Diverse Central Targets, Signaling Mechanisms, and Role in the Pathogenesis of Obesity
Year: 2009
Type: review
Abstract: The groundbreaking discovery of leptin in 1994 ignited the field of obesity research by providing the first direct evidence for a hormonal system primarily involved in body weight regulation. Advances in this field over the past 15 years have led to a detailed understanding of the central targets and mechanisms of leptin action. Although the arcuate melanocortin pathway is currently the best described target of leptin action, in this article we review recent evidence pointing to a system in which leptin acts at distinct sites and through different mechanisms within the central nervous system (CNS) to mediate energy homeostasis and feeding behavior. It appears that leptin controls feeding not just by providing physiological satiety signal, but also by mediating "synaptic plasticity" as well as modulating the perception of reward associated with feeding. Furthermore, we also review advances in our understanding of leptin resistance, a critical consequence and possible precursor of obesity. Leptin is a hormone produced by adipose tissue, acting as a sensor of fat mass in part of a negative feedback loop that maintains a set point for body fat stores. Circulating leptin concentrations closely parallel body fat stores (1), such that a rise in adiposity increases leptin production, hence inhibiting food intake and vice versa. Consequently, both humans and mice with inherited loss of function mutations of the genes encoding either leptin or its receptor display severe early onset obesity (2,3,4,5,6). Leptin deficiency is unique among monogenic obesity syndromes identified so far in that it is amenable to treatment with recombinant leptin (7,8,9). Leptin's role in the negative feedback regulation of body weight is well established in rodents, but there remain some unresolved questions regarding its exact role in humans. Notably, most obese individuals have high leptin levels as predicted, but these do not induce the expected loss in fat mass (10,11,12). Furthermore, despite initial interest in the therapeutic properties of recombinant leptin, administering the hormone to obese individuals does not induce weight loss as predicted, suggesting that obese individuals may be resistant to the effects of leptin (13). A further puzzling finding is that large interindividual variations in serum leptin levels exist, independent of fat mass, in women naturally tending to have higher levels than men (14,15). These observations would suggest that the primary function of the leptin signal is not to prevent excessive weight gain. In fact, evolutionary pressures have geared this system to favor fat storage over fat consumption. Thus the major physiological role of leptin is not as a "satiety signal" to prevent obesity in times of energy excess, but as a "starvation signal" to maintain adequate fat stores for survival during times of energy deficit (16). Although the range of clinical phenotypes of congenital leptin and leptin receptor deficiency is similar, leptin receptor deficiency in humans results in a less severe phenotype (6). It is also believed to be more prevalent than leptin deficiency, and may account for up to 3% of all cases of extreme early onset obesity. The hypothalamic arcuate nucleus (ARC) is a major site for leptin signaling and leptin resistance (17,18,19). Within the arcuate, two distinct classes of neurons exist; one class expresses the peptides POMC (proopiomelanocortin) and cocaine and amphetamine–related transcript which reduce food intake, whereas the other expresses two peptides known as NPY (neuropeptide Y) and AgRP (agouti-related protein) which stimulate feeding behavior (20,21). Leptin receptors are highly expressed on the membranes of both types of neurons allowing leptin to reciprocally regulate these two populations. The leptin receptor is a single membrane spanning protein which shows structural similarity to the class 1 cytokine receptor family (22,23). Several different alternatively spliced isoforms of the leptin receptor (ObR) exist (22), each with a characteristic intracellular domain. Depending upon the length of the intracellular domain the isoforms are classified as either short or long. The short isoforms (ObRa, ObRb, ObRc, ObRd, ObRe, and ObRf) have limited signaling capacity whereas the long isoform ObRb is believed to be the primary signaling form of the receptor (22,24,25). The ObRa and ObRc are expressed at high levels in the cerebral microvessels which constitute the blood–brain barrier and play key roles in leptin transport into the CNS (26). Leptin transport is markedly impaired in both mice lacking the ObR and in mouse models of diet-induced obesity (26). It is generally assumed that this impairment of transport results from a saturation of the leptin transporter due to the high endogenous leptin levels of these mice. In support of this argument, leptin transport has been shown to be normalized in another rodent model of ObR deficiency, the Koletsky rat, when a perfusion method that negates the effect of serum leptin levels is used. It seems likely, however, that short isoforms of the receptor actually modulate the activity of a separate transporter for leptin, whose identity remains unknown (27). The long form of the receptor, ObRb is heavily expressed in the hypothalamus in contrast where it mediates the effects of leptin on energy homeostasis (25,28). The membrane expression of the ObRb is in part regulated by the OB-R gene–related protein which controls endocytic internalization (29). A lack of functional ObRb is responsible for the obesity and metabolic syndrome observed in the db/db mouse model (4). Leptin resistance, a term not without controversy, is used to describe the apparent paradox of leptin's action as an anorectic hormone and its elevated levels in the majority of obese individuals. Conceptually, because it has evolved as a trigger of the starvation response, we are designed to respond to low levels of leptin, which occurs when our fat stores are depleted, and not when it is circulating at normal or elevated levels. There are a number of proposed molecular mechanisms used to describe the phenomenon of leptin resistance. These encompass a spectrum of molecular and functional disorders, which can broadly be characterized into: (i) impaired leptin transport across the blood–brain barrier and (ii) impairment of leptin receptor function and signaling. Importantly, compelling evidence suggests that leptin itself may play an important role in the development of resistance to its own effects, so called "leptin-induced leptin resistance." Chronically raised leptin levels which characterize obesity decrease the transport of leptin into the CNS and impair the signaling properties of leptin receptors. The resulting resistance to leptin confers increased susceptibility to diet-induced obesity, which in turn raises leptin levels further and worsens existing leptin resistance leading to a vicious cycle of weight gain. Therefore in addition to being a major cause of obesity, leptin resistance is also an important consequence (30,31). Studies show that the blood–brain barrier is a crucial site for leptin resistance (32,33,34). At a molecular mass of 16 kDa, leptin is too large to undergo transmembrane diffusion and is transported into the brain by a saturable transport system. Although leptin is widely transported throughout the CNS, the most intensive region of uptake is the hypothalamic ARC. Several factors have been identified to influence the rate of leptin transport into the CNS. α-Adrenergic stimulation for example increases transporter activity (35), whereas hypertriglyceridemia markedly impairs it (36). Hypertriglyceridemia is generally observed during prolonged starvation and it is hypothesized that the ability of triglycerides to inhibit leptin transport may have in part arisen as an evolutionary mechanism to counteract the propagation of anorexic signals during food shortage. Conversely, hypertriglyceridemia is also associated with obesity and may in part be responsible for the impairment of leptin transport that is observed in obese individuals and defines the condition of peripheral leptin resistance (32,33,34). Peripheral resistance like central resistance is both a cause and a consequence of obesity, meaning that the two types of resistance are likely to co-exist and once established set off a vicious cycle of weight gain (32,33,34). Activation of the ObRb initiates a cascade of signal transduction pathways, deficits of which may play an important role in the etiology of leptin resistance. Thought to be of particular importance is the JAK/STAT (Janus kinases/signal transducers and activators of transcription) pathway (24,37). The ObRb has no intrinsic tyrosine kinase activity and therefore must recruit cytoplasmic kinases, especially JAK2 which in turn phosphorylate numerous tyrosine residues of the intracellular domain (37). Although the precise mechanisms of JAK2 activation and signaling remain to be elucidated, a growing body of evidence supports a model in which leptin binding triggers ObRb aggregation into oligomers such that their constitutively bound JAK2 molecules are brought within close contact of each other, hence enabling them to autophosphorylate (38,39,40). It appears that there are three conserved tyrosine residues in the intracellular domain which are phosphorylated and contribute to signaling—Y985, Y1138, and Y1077 (39,41,42) (Figure 1). The phosphorylated domains provide highly specific binding sites for src homology 2 (SH2) domain containing proteins such as STATs which are activated and translocated to the nucleus where they behave as transcription factors. STAT3 is known to be crucial to energy homeostasis, and after binding to the ObR becomes the substrate of receptor-associated JAKs and subsequently dissociates from the receptor before forming active dimers (41). The major signaling pathways activated by the ObR. Ligand binding triggers autophosphorylation of ObR-associated JAK2, which in turn is activated and phosphorylates three critical intracellular tyrosine residues: Y985, Y1077, and Y1138. Phosphorylation of Y985, leads to the activation of extracellular signal–regulated kinase (ERK) signaling, while the phosphorylated Y1077 residue mediates the activation of STAT5. STAT3, which is a transcription factor for proopiomelanocortin (POMC) is activated by Y1138. POMC expression is also increased by signaling through P13K pathway, which inhibits the dephosphorylation of FOXO 1, an inhibitor of POMC transcription. ObR signaling is subject to negative regulation by SOCS3 and protein-tyrosine phosphatase 1B (PTP1B). PDK 1, 3-phosphoinositide-dependent protein kinase 1; STAT, signal transducers and activators of transcription. Mice with a targeted mutation is a key intracellular tyrosine residue (Y1138) of the ObR which is essential for STAT3 activation (s/s) are markedly hyperphagic, obese and at the same time display a suppression of hypothalamic melanocortin activity suggesting that STAT3 may participate in energy homeostasis by regulating the melanocortin gene expression (43). Xu et al. using cre recombinase technology elegantly demonstrated that STAT3 is necessary for inducing POMC transcription. Despite this, however, mice lacking STAT3 in POMC-expressing neurons are responsive to the anorexigenic effects of leptin and display no increased sensitivity to a high-fat diet, highlighting that the STAT3/POMC pathway forms only part of the energy homeostatic response to leptin (44). Current thinking regarding the precise role of the ObR-STAT3 signal in regulating ARC AgRP/NPY-expressing neurons, however, remains unclear. Studies of ARC neuron activity in both db/db and s/s mouse models using c-Fos-like immunoreactivity suggest that the ObR-STAT3 pathway has little, if any, importance in the regulation of orexigenic neurons within the ARC (45). A more recent study, however, specifically targeting STAT3 in AgRP/NPY neurons promotes an important role for this signal in normal energy homeostasis. Mice lacking STAT3 expression in these neurons are hyperphagic, obese, and display increased levels of basal NPY expression although AgRP expression remains relatively constant (46). Whatever the precise role of the STAT3 signal, the significance of other transcription factors including the phosphoinositide 3 kinase (PI3K)-regulated transcription factor of the forkhead-family, FOXO 1 in the regulation of AgRP/NPY neurons cannot be underestimated. SHP-2 is another SH2 domain containing protein which binds to an intracellular tyrosine (Y985) residue phosphorylated by JAK2 and activates the extracellular signal–regulated kinase pathway (47,48). Other pathways known to be activated in response to ObRb activation include the STAT5 (49,50), mitogen-activated protein kinase (24,41), 5′-AMP-activated protein kinase (51), and PI3K (52) pathways. Our understanding of the importance of these individual pathways to the neuroendocrine functions of leptin, however, still remains superficial. The mitogen-activated protein kinase pathway may play a role in the regulation of linear growth and reproductive function whereas PI3K signaling is believed to contribute to energy homeostasis (43). Leptin receptor stimulation mediates the tyrosine phosphorylation of insulin receptor substrate proteins by JAK2, independently of tyrosine phosphorylation sites on the ObRb (53). Insulin receptor substrate in turn recruits, phosphorylates, and activates PI3K, leading to an accumulation of its product phosphatidylinositol 3,4,5-triphosphate. Phosphatidylinositol 3,4,5-triphosphate activation leads to sequential activation of 3-phosphoinositide-dependent protein kinase 1 and AKT culminating in the inhibition of FOXO 1, which is known to inhibit POMC expression. Evidence supporting the role of PI3K signaling in energy homeostasis includes the following observations: (i) mice lacking insulin receptor substrate 2 are hyperphagic and obese (54), (ii) pharmacological blockade of PI3K activity blocks the anorectic effect of leptin (53), (iii) chronic activation of the P13K pathway, by the deletion of an inhibitory regulator PTEN leads to diet-induced obesity (55), and (iv) mice lacking 3-phosphoinositide-dependent protein kinase 1 in POMC-expressing neurons display an obese phenotype which can be reverted by inhibiting FOXO 1 activation (56). A role for PI3K signaling has also been proposed in leptin-mediated stimulation of sympathetic outflow (57). Importantly, the PI3K pathway is also the major intracellular pathway activated by insulin receptor signaling, making this a crucial stage at which leptin and insulin may coordinately act to control energy homeostasis. The insulin–P13K pathway hyperpolarizes POMC neurons via adenosine triphosphate sensitive K+ channels, thereby reducing their sensitivity to leptin (55). This may be an important mechanism by which overfeeding leads to impaired leptin sensitivity. The JAK/STAT pathway is subject to negative feedback regulation by the SOCS family of proteins (58,59,60). In particular, leptin signaling via Y1138 and STAT3 induces the expression of SOCS3 mRNA in the hypothalamus, which has been shown to inhibit the phosphorylation and activation of JAK2 and Y985 (61,62,63). In fact, over expression or over activation of SOCS3 is a proposed mechanism for leptin resistance, particularly in diet-induced obese states (64). In other words, adiposity and increased levels of leptin in obesity enhance SOCS3 expression which serves to dampen leptin receptor signaling, resulting in a nonlinear relationship between leptin concentration and signaling response. Reducing SOCS3 activity in mice either by neuron-specific conditional knockouts or heterozygous global knockouts enhances both STAT3 expression and the weight reducing effects of peripherally administered leptin (65,66). Furthermore, genetically engineered mice (l/l), with a mutation in a key tyrosine residue (Y985) responsible for the activation and recruitment of both SOCS3 and SHP-2 display reduced feeding and adiposity, increased STAT3 activation and increased sensitivity to leptin (41,67). Although the loss of SHP-2 recruitment in these mice may reduce anorectic effect, it is believed that this is more than compensated by the loss of the inhibitory signal from SOCS3 hence resulting in a net anorectic effect. Nevertheless, there is conflicting evidence regarding the exact role of SOCS3 as its mRNA levels have been found to be similar in both l/l and wild-type mice, leading to the presumption that SOCS3 alone cannot mediate the entirety of the inhibitory effects of the Y985 residue. Interestingly, the s/s mouse described earlier also displays some unique features compared to wild types and db/db mice, including enhanced immune function, increased linear growth, and reduced attenuation of JAK2 and STAT3 signaling in response to prolonged receptor stimulation (43,68,69,70). This is possible by virtue of the loss of the inhibitory signal from SOCS3. Another molecule which has attracted interest for its role in the negative regulation of leptin signaling by dephosphorylating JAK2 is protein-tyrosine phosphatase 1B (PTP1B) (71,72,73). Although studies have confirmed that neuron-specific or global PTP1B knockouts increase leanness and leptin sensitivity, PTP1B expression and activity remain independent of leptin or body fat mass, highlighting that this molecule may not directly contribute to perturbations of leptin signaling observed in obesity (71,73,74,75). It appears, therefore, that leptin-responsive neurons implement rather complex mechanisms of controlling their own sensitivity to leptin. But what is the physiological and evolutionary function of this? Interestingly it has been suggested that leptin resistance may be a mechanism of helping to detect energy flux (the rate of energy expenditure) rather than the current energy stores alone. The determination of energy flux is a more accurate indicator of the true energy balance and the future energy requirements of an organism. For example an organism may still be in negative energy balance despite having high energy/fat stores during pregnancy, illness, or intensive exercise. A system which dampens leptin responses in high energy states is more sensitive to negative energy flux as it is less likely to be potentially disastrously overwhelmed by strong anorexic signals. The concept of reversing central leptin resistance using pharmacological agents which target the negative regulators of leptin signaling is promising. However, there exists a difficulty in these molecules that are ubiquitously expressed both centrally and peripherally and play important roles in a number of signaling processes. Any drug designed to target either SOCS3 or PTP1B for in order to enhance STAT3 activation in hypothalamic centers concerned with energy homeostasis will disrupt many other signaling properties of these proteins unless it acts highly specific. The critical importance of SOCS3 for example is confirmed by the finding that SOCS3 mice in although PTP1B mice are and resistant to diet-induced obesity, the is believed to important roles in cycle and growth factor receptor signaling, and responses to Another of leptin sensitivity is to enhance the membrane expression of its receptors. earlier OB-R expression is regulated by the OB-R gene–related of this transcript enhances both hypothalamic OB-R expression and signaling as well as resistance to diet-induced obesity. Interestingly, despite the in membrane expression of the of the STAT3 expression without having an effect on P13K expression. Consequently, targeting this pathway may not homeostasis (29). It is that in addition to within the leptin also between et al. elegantly demonstrated that leptin can induce in the balance of and inhibitory to both and neurons In this study, a used to that mice have increased inhibitory on POMC-expressing neurons and increased on neurons compared to their wild-type These with of the of inhibitory and to the two of leptin treatment of mice a of the balance of to these two of neurons within just Although this of occurs over a time than the observed in feeding its importance to normal energy homeostasis is by the that another has a similar effect In addition to its role in leptin has also been as a and may be responsible for the development during the of specific both within the arcuate and between the arcuate and other hypothalamic centers involved in energy homeostasis including the nucleus hypothalamic and hypothalamic arcuate can be in mice by administering leptin but not in These support the that a leptin acts as a signal to arcuate and the of pathways which control energy homeostasis. its role in the hypothalamus, leptin is also proposed to play an important role in which and within the A likely model for leptin action is it POMC and cocaine and amphetamine–related transcript neurons by through a while inhibiting and neurons from NPY to POMC neurons, such that POMC neurons are also in part activated through A recent has demonstrated effects of leptin on in and Leptin signaling increases the current in POMC-expressing neurons while reducing the current in NPY Furthermore, it appears that these effects may be on protein kinase pathways in NPY neurons and on pathways in POMC neurons Although the evidence the arcuate as a of leptin's is both compelling and it by no to the of leptin's effects on energy homeostasis. deletion of the leptin receptor in POMC neurons or its in the arcuate of db/db only body weight and is not to alone the obesity of or db/db although s/s mice are markedly obese and hyperphagic, targeted of STAT3 from arcuate POMC and AgRP/NPY neurons only in a obese phenotype therefore, seems likely that leptin acts to control energy homeostasis through of neurons, the precise functions of many of which remain to be the hypothalamic targets of leptin are the hypothalamus, and the Although our understanding of the individual functions of each of these however, remains two which have attracted recent interest for their roles are the nucleus and It has been known for some time that of the in mice and obesity. it has been demonstrated that a of neurons in the to satiety via to the arcuate, the of these being regulated by leptin the sensitivity of the to leptin In the importance to normal energy homeostasis of a of neurons the transcription factor demonstrated by the of obesity in mice following deletion of the in these neurons using technology The JAK/STAT pathway is an important of leptin's in these neurons, as targeted of SOCS3 both leptin sensitivity and homeostasis of the or the deletion of a single of 1, a gene encoding a transcription factor necessary for the normal development of the obesity in both mice and humans more the of the in the of mice their and obesity despite the lack of the within the arcuate In addition to containing a the the also from neurons within the arcuate hence allowing for direct and regulation by leptin. A of in mice and mice either leptin or treatment has a number of genes which may be regulated by leptin at this site leptin's role in it is that among the 15 genes regulated by leptin, shown to be in function or of which are in and development and whereas the may and Furthermore, pathway to of that of the genes regulated by leptin play important roles in protein which is an part of function and this also genes encoding proteins involved in particularly complex 1 proteins regulating to be the gene set regulated by leptin These suggest that leptin may influence both function and such that a from to which is by leptin. numerous studies have phosphorylation gene expression in the of with 2 a condition that is associated with obesity, the that phosphorylation may be a central and peripheral mechanism for controlling body weight of phosphorylation gene expression may contribute both to obesity and A growing body of evidence also supports a role for including such as the nucleus as target sites for leptin signaling (20,21). The nucleus neurons and also from the including and The of leptin at the are also proposed to contribute to the perception of reward (Figure A of the physiological and mechanisms by which leptin satiety and feeding behavior. Leptin the physiological to at hypothalamic sites including the nucleus arcuate nucleus hypothalamic nucleus hypothalamus and the nucleus The nucleus an important role as an of hormonal signals including leptin, and effects on reward through the pathway, at the of the The of or not to is a complex that is not only by physiological but also by a of other factors including the that reward This is by the all too of on particularly despite In fact, recent evidence that in addition to its role in the physiological of satiety leptin, it may also regulate the of satiety by the perception of reward associated with feeding. This action of leptin occurs at the of the which appears to independently of with the this system may the weight gain by which act as receptor Leptin receptors are highly expressed on neurons within the of the which to brain including the and Interestingly, the hypothalamus is likely to be an important regulator of this pathway as it of and hormone containing neurons by leptin signaling which to the and the Leptin inhibits the activity of neurons while inhibiting the expression of the effect of which may be to modulate the signal and reduce food intake In support of leptin's inhibitory effect on reward leptin has been shown to decrease the rate of in the of the hypothalamus in states Furthermore, the hypothalamus has also been shown to a of neurons which to the allowing leptin to both directly and modulate this studies have also an important role for leptin in the of The activity of the and using functional and with of food in the and these individuals with leptin, food and with activity in only the and not the These support a role for leptin in the or reward associated with feeding functional studies have also the for such as and to regulate feeding reward through the system Interestingly, in contrast to leptin's effects on the to influence possible sites of action. The of a physiological system for modulating feeding behavior on reward is puzzling but may provide an in times of food allowing excessive food and energy storage In the current global obesity however, it seems that the ability of leptin and other to dampen reward is overwhelmed by the excessive of highly may therefore be important factor in the of obesity. Although we have to the that a number of peripheral and central signals contribute to energy homeostasis, in this article we specifically on the leptin signal as an model of body weight review the evidence the that leptin acts primarily at the ARC to control satiety through the melanocortin an is leptin acts through a of neurons to control both the physiological and of The no of
Source: Obesity
DOI: 10.1038/oby.2009.228
Authors: Ashwini Oswal, Giles Yeo
Institutions: Addenbrooke's Hospital, University of Cambridge
Language: English
Subfield: Endocrine and Autonomic Systems
Field: Neuroscience
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2059926508
